Batya Isaacson Selected Research

Natural Cytotoxicity Triggering Receptor 1

12/2020	Altered NKp46 Recognition and Elimination of Influenza B Viruses.
1/2018	NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis.
1/2018	NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis.
10/2017	NKp46 Recognizes the Sigma1 Protein of Reovirus: Implications for Reovirus-Based Cancer Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Batya Isaacson Research Topics

Disease

10	Neoplasms (Cancer) 01/2021 - 01/2015
4	Infections 12/2020 - 10/2016
2	Neoplasm Metastasis (Metastasis) 01/2018 - 01/2018
1	Human Influenza (Influenza) 12/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Melanoma (Melanoma, Malignant) 10/2017
1	Reoviridae Infections 10/2017
1	Urinary Tract Infections (Urinary Tract Infection) 01/2017

Drug/Important Bio-Agent (IBA)

6	LigandsIBA 01/2020 - 01/2015
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2015
4	Natural Cytotoxicity Triggering Receptor 1IBA 12/2020 - 10/2017
2	Fibronectins (Fibronectin)IBA 01/2018 - 01/2018
2	InterferonsIBA 01/2018 - 01/2018
2	Natural Killer Cell ReceptorsIBA 01/2017 - 01/2015
1	Carcinoembryonic AntigenIBA 01/2021
1	CEACAM1 ProteinIBA 01/2021
1	Viral ProteinsIBA 12/2020
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 12/2020
1	Hemagglutinins (Hemagglutinin)IBA 12/2020
1	VaccinesIBA 12/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	AntibodiesIBA 01/2020
1	Thomsen-Friedenreich antigenIBA 01/2020
1	LectinsIBA 01/2020
1	Extracellular Matrix ProteinsIBA 01/2018
1	Chemokine CXCL12IBA 01/2017
1	micaIBA 01/2017
1	Viral HemagglutininsIBA 01/2015

Therapy/Procedure

3	Therapeutics 01/2020 - 10/2017
1	Immunotherapy 01/2020